D61.01 Constitutional (pure) red blood cell aplasia

Name of the Condition

• Constitutional (pure) red blood cell aplasia (ICD-10 Code D61.01)

Summary

Constitutional (pure) red blood cell aplasia is a rare disorder characterized by selective failure of the bone marrow to produce red blood cells, while other blood cell lines (white blood cells and platelets) remain unaffected. This results in anemia, but without the typical bleeding or infection risks associated with generalized bone marrow failure. The condition is often present from birth or early childhood and may be inherited.

Causes

The condition is caused by genetic mutations that specifically impair the development or function of erythroid progenitor cells in the bone marrow. These mutations disrupt the production of red blood cells while sparing other hematopoietic lineages. Inherited patterns may vary, and the exact genetic defects are often linked to pathways critical for red blood cell maturation.

Risk Factors

• Family history of constitutional red blood cell aplasia or related erythropoietic disorders.
• Consanguinity (parents who are closely related) increasing the likelihood of inheriting recessive genetic mutations.
• Presence of other congenital anomalies or syndromes associated with isolated red blood cell production defects.

Symptoms

• Persistent fatigue and weakness due to anemia.
• Pale skin and shortness of breath with exertion.
• No increased risk of infections or bleeding, as white blood cell and platelet counts are typically normal.

Diagnosis

Diagnosis requires blood tests showing isolated anemia (low red blood cell count) with normal white blood cell and platelet counts. A bone marrow biopsy is essential to confirm selective erythroid hypoplasia or aplasia, ruling out other causes of anemia. Genetic testing may be used to identify underlying mutations.

Treatment Options

• Supportive care, including red blood cell transfusions to manage anemia.
• Erythropoiesis-stimulating agents (ESAs) to promote red blood cell production.
• In severe or refractory cases, hematopoietic stem cell transplantation may be considered.

Prognosis and Follow-Up

Prognosis depends on the severity of anemia and response to treatment. Lifelong monitoring is often necessary to manage transfusion needs and assess for complications. Regular follow-up with a hematologist is recommended to adjust therapy and address any emerging issues.

Complications

• Iron overload from repeated transfusions, requiring chelation therapy.
• Potential for progression to more generalized bone marrow failure in rare cases.
• Delayed growth or development in children due to chronic anemia.

Lifestyle & Prevention

• Maintain a balanced diet rich in iron and vitamins to support overall health.
• Avoid unnecessary exposure to toxins or medications that may exacerbate anemia.
• Follow medical advice for managing transfusion-related risks, such as iron overload.

When to Seek Professional Help

Seek immediate medical attention if you experience severe fatigue, dizziness, or shortness of breath that interferes with daily activities, or if you notice signs of worsening anemia (e.g., increased pallor, rapid heartbeat).

Tips for Medical Coders

Document the selective nature of red blood cell aplasia, including bone marrow findings and genetic testing results when available. Ensure the code D61.01 is used only when the condition is constitutional (inherited) and not secondary to other causes. Include details on treatment response and transfusion history to support clinical coding accuracy.